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Retrospective Analysis of Esophageal Heat Transfer for Active
Temperature Management in Post-cardiac Arrest, Refractory
Fever, and Burn Patients
Melissa Naiman, PhD*; Andrej Markota, MD†; Ahmed Hegazy, MD‡; John Dingley, MD§;
Erik Kulstad, MD║
ABSTRACT Core temperature management is an important aspect of critical care; preventing unintentional hypo-
thermia, reducing fever, and inducing therapeutic hypothermia when appropriate are each tied to positive health out-
comes. The purpose of this study is to evaluate the performance of a new temperature management device that uses the
esophageal environment to conduct heat transfer. De-identiﬁed patient data were aggregated from three clinical sites
where an esophageal heat transfer device (EHTD) was used to provide temperature management. The device was eval-
uated against temperature management guidelines and best practice recommendations, including performance during
induction, maintenance, and cessation of therapy. Across all active cooling protocols, the average time-to-target was
2.37 h and the average maintenance phase was 22.4 h. Patients spent 94.9% of the maintenance phase within ±1.0°C
and 67.2% within ±0.5°C (574 and 407 measurements, respectively, out of 605 total). For warming protocols, all of
the patient temperature readings remained above 36°C throughout the surgical procedure (average 4.66 h). The esoph-
ageal heat transfer device met performance expectations across a range of temperature management applications in
intensive care and burn units. Patients met and maintained temperature goals without any reported adverse events.
INTRODUCTION
Temperature management is a standard of care across special-
ties; approximately 20 million cases each year in the United
States warrant active temperature management. Preventing
unintentional hypothermia, reducing fever, and inducing ther-
apeutic hypothermia when appropriate are each tied to posi-
tive health outcomes and patients who develop uncontrolled
hyperthermia or hypothermia experience worse outcomes.
Patients who experience even mild cases of perioperative
hypothermia (<1°C) lose ~16% more blood and are at ~22%
increased relative risk for transfusion.1 Trauma patients admit-
ted with a core temperature reading of <35°C were associated
with a signiﬁcantly increased mortality at 24 hr and 28 d (OR
2.72 [1.18–6.29] and OR 2.82 [1.83–4.35]), respectively.2
Cardiac arrest patients who develop fever following targeted
temperature management experience increased mortality at 30
d and worsened neurological outcomes at 1 yr.3 In cases of
severe traumatic brain injury, induced normothermia lowers
mean intracranial pressure and lowers the total amount of
time patients exhibit intracranial pressure over 25mmHg.4
Targeted temperature management is strongly recommended
in post-resuscitation guidelines issued by the American Heart
Association5 and European Resuscitation Council,6 among
other professional societies. Most recently, the World Health
Organization recommended actively warming surgical patients
to prevent surgical site infections.7
Despite extensive clinical evidence, active temperature man-
agement is either underutilized8 or inadequately applied9 in crit-
ical care populations. Both scenarios may be partially attributed
to clinical challenges associated with the advanced devices
used to control patient temperature. It is well established that
advanced temperature management methods are more efﬁcient
than ad hoc methods, such as chilled saline bolus or ice packs.
Advanced methods incorporate servo-controlled temperature
monitoring, which allows a temperature management protocol
to be automated and meet the patient’s exact needs. Currently,
the most common commercially available devices use one of
three mechanisms to modulate patient core temperature: intra-
vascular convection, surface convection, or surface conduction.
Intravascular devices rely on the surgical placement of a spe-
cialized central venous catheter; this method is effective, but
must be placed by a trained physician under sterile conditions
and requires access to a major blood vessel. Once placed,
patients face an increased risk of Central Line Associated
Blood Stream Infection10 and thrombosis.11 Surface devices
that conduct heat through the skin obstruct patient access
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require that skin must be mostly intact and can cause skin dam-
age and infection.12,13 There is no evidence to support that one
technique is better than the other,14 so current recommenda-
tions support the use of any active temperature management
method that a clinician is comfortable with and makes sense in
their operational setting.5
Considering these risks, a new temperature management
device was developed15 that performs heat transfer in the
esophageal environment (Fig. 1). The device is constructed
from medical grade silicone and connects to commercially
available heat exchange units (commonly available in acute
care settings) that circulate temperature-controlled water
within the device (i.e., water never enters the GI tract, in con-
trast to lavage techniques). Any YSI 400 compatible tempera-
ture probe can be used to automate temperature monitoring.
The risk proﬁle and patient management requirements are
similar to a standard OG tube. The device may be damaged
by jaw clenching or chewing, so bite block placement is
recommended. Prolonged contact with oral mucosa can result
in minor lesions, so moving the tube regularly and/or using a
securement device, such as a endotracheal tube holder, is
strongly recommended. Patients receiving endoscopy follow-
ing esophageal heat transfer have presented with esophageal
lesions, but these were consistent with OG tube placement
and not attributable to the device itself.16 The purpose of this
study is to evaluate the performance of an esophageal heat
transfer device (EHTD) in a variety of critical care scenarios.
EVALUATING ACTIVE TEMPERATURE
MANAGEMENT DEVICES
Currently, there is not a “gold standard” for temperature
management protocols, which creates some challenges when
evaluating new temperature management devices. However,
there is emerging clinical research and published best prac-
tices that can provide guidance for technology assessment.
In the critical care environment, temperature management
protocols (whether the goal is to reduce or increase core tem-
perature) are described in three phases: induction, mainte-
nance, and cessation of therapy.
Most modern studies measure induction in terms of time-
to-target, deﬁned as the time from the initiation of therapy
until the goal temperature is achieved.17,18 For cooling pro-
tocols, the clinical importance of this parameter is derived
from the relationship between reduced temperature and the
downregulation or reduction of neurodegenerative biochemi-
cal processes, including mitochondrial dysfunction and apopto-
sis, glutamate release and free radical production, blood–brain
barrier and cell membrane permeability, and brain metabol-
ism.19 Resuscitation guidelines are the most explicit; the American
Heart Association Guidelines and European Resuscitation
Council Guidelines recommend patients reach target tempera-
ture within 4 hr after return of spontaneous circulation.5,6
There is insufﬁcient evidence to support formal guidelines for
time-to-target goals in patients experiencing forms of ische-
mia–reperfusion injury other than sudden cardiac arrest, but
there is clinical evidence that fever (usually deﬁned as body
temperature above 38°C) aggravates inﬂammatory cascades
that lead to worsened health outcomes;20–22 therefore, active
fever prevention or reversal is a standard practice. When apply-
ing these guidelines and best practices to technology evaluation,
to be clinically useful, an active temperature management device
should demonstrate the ability to reach target temperature in
under 4 hr.
The rationale for active warming is derived from another
series of biochemical events linked to temperature, speciﬁ-
cally coagulopathy and immune response.1 There is sufﬁ-
cient evidence for the World Health Organization to issue a
clinical guideline23 that surgical patients should not experi-
ence a core temperature below 36°C at any point. Therefore,
a relevant active temperature management device should
maintain a temperature of at least 36°C as a procedure
begins. In the case of severe burn patients, this may require
the initiation of active warming preoperatively.
Once target temperature is achieved, the second phase of a
temperature management protocol, most frequently termed
“maintenance,” begins. For cooling protocols, the purpose of
monitoring core temperature maintenance is to optimize neu-
roprotection. Poor neurological outcomes are associated with
imprecise temperature maintenance,14,24 although there is
FIGURE 1. The EHTD is placed into the esophagus to conduct heat trans-
fer. The device connects to standard suction (central lumen) and a standard
water blanket chiller (two outer lumens) to circulate temperature-controlled
water within the device.
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insufﬁcient evidence to support a clinical guideline for a devi-
ation threshold. Therefore, the research community typically
deﬁnes a “minor” deviation as greater than ± 0.5°C and deviations
up to ±1.0°C are considered acceptable.14,20,24 In warming
protocols, the goal is to maintain temperature above 36°C
for the duration of the procedure, but how far above that
threshold is left to clinicians’ discretion. In both scenarios,
maintenance is typically reported as the proportion of time
a patient remained within a deﬁned range of the target.
Therefore, to be clinically relevant, a temperature manage-
ment device should be able to maintain a precise tempera-
ture from the time target is attained until the course of
treatment is completed.
The ﬁnal phase of a temperature management protocol is
cessation of therapy. During cessation, patients must be moni-
tored closely to ensure that discontinuing therapy is appropri-
ate. In cooling protocols, and especially in post-cardiac arrest
patients, rebound hyperthermia is a signiﬁcant concern.25 To
counteract this phenomenon, patients are rewarmed slowly
(AHA guidelines recommend a rate of 0.25°C−0.5°C5) over a
12-h period. In neurogenic and central fever cases, temperature
spikes can be unpredictable and may occur for several weeks.26
In warming protocols, temperature should not be permitted to
drop below 36°C during recovery, although this metric is often
not reported as part of perioperative temperature management
studies. Therefore, to be clinically relevant, a temperature man-
agement device should demonstrate the ability to affect gradual
temperature change without allowing rebound hyperthermia. It
should also accommodate transitions across care sites (e.g.,
from the operating room to recovery) and resumption of ther-
apy with minimal risk to the patient.
METHODS
De-identiﬁed data from patients treated with active tempera-
ture management using an EHTD (Catalog No. EnsoETM
ECD01 or ECD02; Attune Medical, Chicago, IL, USA) were
aggregated from three clinical sites for retrospective analysis.
Patient demographics were reviewed to conﬁrm consistency
with device instructions for use (i.e., patient mass between
40 kg and 200 kg). Records were also reviewed for completeness
to conﬁrm that core temperature readings for each patient
were recorded hourly; if measurements were recorded more
frequently, temperature over an hour span was averaged. In
all cases, EHTDs were connected to a Blanketrol III (Cincinnati
Subzero, Cincinnati, OH, USA) or CritiCool (MTRE, Rehovot,
Israel) commercially available heat exchange unit and core tem-
perature measurements were obtained from a YSI 400 enabled
Foley temperature probe placed in the bladder.
The evaluation criteria were established to mirror the three
phases of temperature management protocols observed in criti-
cal care environment: induction, maintenance, and cessation of
therapy (rewarming in post-cardiac arrest patients). Induction
was evaluated by calculating the time-to-target, deﬁned in this
study as the time, in hours, from device placement to ﬁrst tem-
perature reading within ± 1°C of target. The maintenance phase
was deﬁned as the ﬁrst measurement after target was achieved
until therapy concluded (indicated by the initiation of a rewarm-
ing protocol in post-cardiac arrest patients or conclusion of
therapy in all others). Maintenance stability was deﬁned as the
proportion of core temperature measurements within the target
range during the maintenance phase. Rebound hypothermia
was deﬁned as any temperature readings above 38°C recorded
after target temperature had been achieved in post-cardiac arrest
protocols. Fever burden was deﬁned as the average amount of
time, in hours, a patient demonstrated temperature measure-
ments above 38°C in fever reversal cases.
RESULTS
A dataset of 1,000 core temperature readings was con-
structed from 30 patient records, representing 27 cooling
protocols (23 post-cardiac arrest patients and 4 fever reversal
patients) and 3 perioperative warming protocols for severe
(~50% body surface area) burn patients. Across all protocols,
the average deviation (calculated as actual temperature − tar-
get temperature/no. of readings at a time point, Fig. 2) from
target at any time point was 0.43°C (SD = 0.72°C).
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FIGURE 2. Average deviation (blue line) was calculated by subtracting the target temperature from the goal temperature and dividing by the total mea-
surements recorded at a given time point. The error bars represent the standard deviation calculated for all measurements recording at a given time point.
The increased variations in the ﬁrst 4 hr are attributed to heterogenous starting temperatures across the patient population, especially among post-cardiac
arrest cases with a 33°C target temperature. Increased variation toward the end of the protocol is consistent with unique patient response to rewarming, rang-
ing from no excursions (typically if the patient suffered major neurological insult) to rebound hyperthermia.
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Cooling Protocols
Across all active cooling protocols, the average time-to-
target was 2.37 h (range 0–14 h, SD ± 2.8 h) and the average
maintenance phase was 22.4 h (range 13–31 h). Patients
spent 94.9% of the maintenance phase within ±1.0°C and
67.2% within ±0.5°C (574 and 407 measurements, respec-
tively, out of 605 total).
In post-cardiac arrest patients, average time-to-target was
1.78 h (range 0–6 h, SD ± 1.67 h), the average maintenance
phase was 22.4 h (range 19–24 h). The average rewarming
rate was 0.20°C/h and only one patient demonstrated fever
rebound, with readings at 38.1°C–38.2°C for a total of 2 h
(Fig. 3). The average time-to-target for fever reversal cases
was 5.75 h (range 2–14 h) and average fever burden was
4.5 h (14.9% of total treatment time, Fig. 4). One case repre-
sented a signiﬁcant deviation from other cooling protocols.
Patient 27 was in treatment for severe burns and developed
refractory fever subsequent to skin graft surgery.27 In this
case, the patient had been febrile for several hours before
cooling was initiated and active cooling was concluded once
the patient had maintained a core temperature below 38.5°C
for ﬁve consecutive hours, with a total fever burden of 13 h
(72.2% of total treatment time). The other three cases were
refractory fever with infectious origins who were actively
cooled for between 32 h and 36 h with an average fever bur-
den of 1.66 h (7.14% of total treatment time).
Warming Protocols
In the warming cases, patients were warmed before entering
the operating room and the objective was to avoid periopera-
tive hypothermia while reducing the ambient temperature
from 30°C to ~26°C.27 All of the patient temperature read-
ings remained above 36°C throughout the surgical procedure
(average 4.66 h, Fig. 5).
DISCUSSION
Based on the evaluation criteria established in this study, the
EHTD could perform a variety of temperature management
protocols. The average induction time of 2.37 h was well
within the cardiac arrest guidelines and refractory fever rec-
ommendations of 4 h from the initiation of therapy until
target was achieved. The EHTD also demonstrated stable
temperature maintenance, patients who received a cooling
protocol spent 94.9% of the maintenance phase within ± 1.0°C,
and patients who received a warming protocol avoided inad-
vertent perioperative hypothermia for 100% of the surgical
time. Cessation for cardiac arrest patients was controlled
FIGURE 3. A total of 23 post-cardiac arrest, patients were treated with either a 33°C protocol (blues) or 35°C protocol (greens). The observed average
time-to-target was 1.74 h and patients spent 94.9% of the maintenance phase within ±1.0°C and 67.2% within ±0.5°C (574 and 407 measurements, respec-
tively, out of 605 total).
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(rewarming rate of 0.20°C/h) and instance of rebound hypo-
thermia was not signiﬁcant.
This analysis supports EHTD effectiveness in real-world
clinical settings; however, the dataset has some limitations.
First, the dataset represented a very heterogenous sample in
terms of many factors that affect temperature management,
such as body composition, age, and comorbidities (details of
many of the cases can be found elsewhere in the litera-
ture).28–33 Second, mild hypothermia protocols dominated
the dataset (76% overall, and 56% received a 33°C target
protocol) and were a potential source of bias. Finally, as this
analysis is based on the data collected in hospital, it is
impossible to account for the inﬂuence of any pre-hospital
interventions, such as administering chilled saline. However,
FIGURE 4. In four refractory fever cases, patients were treated with either a 36.5°C protocol or a 38.5°C protocol. The average time-to-target for fever
reversal cases was 5.75 h (range 2–14 h) and average fever burden was 4.5 h (14.9% of total treatment time). Patient 27, the only recipient of a 38.5°C proto-
col, was in treatment for severe burns and developed refractory fever subsequent to skin graft surgery. The patient had been febrile for several hours before
cooling was initiated and active cooling was withdrawn once the patient had maintained a core temperature below 38.5°C for ﬁve consecutive hours.
FIGURE 5. A warming protocol was conducted on three patients receiving skin graft surgery for severe burns. All patient temperature readings remained
above 36°C throughout the surgical procedure (average 4.66 h).
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such interventions would be most inﬂuential on time-to-
target, but unlikely to inﬂuence maintenance stability or
post-hypothermia fever.
Despite these limitations, this evaluation has important
future implications to temperature management in military
medicine. First, the EHTD offers a new and effective tem-
perature management technique that could be applied in for-
ward critical care environments. Esophageal heat transfer
offers several logistical advantages over surface and intra-
vascular devices. The EHTD does not require extensive per-
sonnel to initiate treatment. Intravascular devices often
require up to 30–45 min of hands-on physician and nursing
time to set up and place, using sterile technique. Surface
devices often require up to 15–20 min of hands-on time (and
extensive patient manipulation) from two to three nurses.
The EHTD can be placed in under 5 min by any provider
trained to place an OG tube. Further, the EHTD is platform
agnostic. Current surface and intravascular devices are
designed only to connect within their own brand. The EHTD
is designed to connect with the three most popular water
blanket heat exchangers and evaluations are ongoing to
expand approvals to other commercially available heat
exchangers. This facilitates continuity of care during evacua-
tion or transfers.
The EHTD can also be used in many severe burn cases.
Clinicians treating burn patients often avoid surface and
intravascular warming methods because any additional infec-
tion risk is considered unacceptable. Before the introduction
of the EHTD, if surface and intravascular devices were
excluded, the only remaining option available to counter
perioperative hypothermia was elevating operating room
ambient temperature as much as possible, sometimes up to
110 °F (43.3°C). However, raising room temperature is
highly inefﬁcient and transfers, at most, 13.2W of energy to
the patient35 while creating an extremely uncomfortable
environment for the surgical team. In contrast, esophageal
heat transfer delivers up to 30W of energy to the patient,
regardless of operating room temperature.35 In practice, dur-
ing major burn excisions, anesthesiologists have used the
EHTD to maintain normothermia in severe burn patients for
up to 6 h in an OR kept at ~80 °F (26°C).33
CONCLUSIONS
The data presented in this evaluation support that the EHTD
meets the requirements for optimal temperature management
in a variety of critical care patients. In addition to quantitative
effectiveness measures, the device also offers several clinical
and logistical advantages that may be of importance to ﬁeld
medicine. Taken together, these characteristics provide an
opportunity to move temperature management (an established
standard of care) forward. Additional studies are in progress
to demonstrate the feasibility of the EHTD in other clinical
environments. Research is underway to explore how anesthe-
sia affects esophageal heat transfer, which will ultimately
support clinical trials in inadvertent perioperative hypothermia
prevention during procedures with substantial temperature
management challenges, such as trauma surgery, spine sur-
gery, and open abdominal/thoracic surgery. EHTD perfor-
mance in cooling procedures will be further evaluated through
data collected in a neurointensive care unit registry, focusing
on subarachnoid and intracranial hemorrhage patients. Each
of these studies will contribute to the overarching body of
knowledge that will ultimately lead to expanded evidence-
based temperature management guidelines that reach beyond
resuscitation.
PRESENTATIONS
Presented as an oral presentation at the 2016 Military Health System
Research Symposium (abstract number: MHSRS-16–1054).
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